A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC

by Sarina Piha-Paul, MD, George Simon, MD, Chandra P. Belani, MD, Heman Chao, PhD, Kim Gaspar, PhD, Brenda Lee, MSc, Afshin Dowlati, MD
Published 2022-11-01